Nippon India Pharma Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹166 Cr | ₹7404 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 01 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open-ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.34 | 1.82 |
| Manager | Rohan Korde | Sailesh Raj Bhan |
| ISIN Code | INF00XX01BL5 | INF204K01968 |
| Exits Load | Exit load of 1% if redeemed within 12 months./365 | Exit load of 1% if redeemed within 1 month./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 6.02% | 6.25% |
| 6 Month | 20.76% | 19.11% |
| 1 Year | 49.89% | 47.43% |
| 3 Year | - | 18.54% |
| 5 Year | - | 30.13% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 14.47% | 17.1% |
| 3 Year | 35.63% | 43.51% |
| 5 Year | 35.63% | 81.66% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 18.13% | 26.16% |
| 3 Year | 38.24% | 53.8% |
| 5 Year | 38.24% | 80.65% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 14.52% | 14.36% |
| Sharp | - | 0.68% |
| Beta | - | 0.91% |
| Alpha | - | 1.57% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Rohan Korde | Sailesh Raj Bhan |
| Total AUM | ₹4626 Cr | ₹96086 Cr |
| Fund Manage | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 0.48 | 1.66 |
| Mid Cap | 28.05 | 35.52 |
| Small Cap | 32.19 | 20.97 |
| Large Cap | 39.28 | 41.85 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 0.48 | 1.66 |
| Healthcare | 96.77 | 98.34 |
| Chemicals | 2.75 | - |
Top Comparisons
HSBC Large & Mid Cap Fund - Regular Growth
3Y Returns22.25%
Edelweiss Large & Mid Cap Fund - Regular Plan - Growth Option
3Y Returns20.91%
Nippon India Money Market Fund-Growth Plan-Growth Option
3Y Returns6.41%
Aditya Birla Sun Life Money Manager Fund - Growth
3Y Returns6.38%
WhiteOak Capital Special Opportunities Fund-Reg (G)
3Y Returns0%
Tata Nifty Realty Index Fund - Regular (G)
3Y Returns0%
Bandhan Retirement Fund - Regular (G)
3Y Returns0%
Tata Retirement Savings Fund - Progressive Plan -Regular Plan-Growth Option
3Y Returns16.37%